| 9/21/2021 |
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $710.00 |
dispatchtribunal.com |
Thermo Fisher Scientific (NYSE:TMO) had its price target lifted by KeyCorp from $555.00 to $710.00 in a report published on Monday morning, The Fly reports. KeyCorp currently has an overweight rating on the medical research company’s stock. TMO has been the topic of several other reports. SVB Leerink reaffirmed an outperform rating on shares of Thermo Fisher Scientific in a research report on Monday, July 19th. Robert W ... |
| 9/21/2021 |
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $710.00 at KeyCorp |
thelincolnianonline.com |
Thermo Fisher Scientific (NYSE:TMO) had its price objective boosted by KeyCorp from $555.00 to $710.00 in a research note published on Monday morning, The Fly reports. They currently have an overweight rating on the medical research company’s stock. A number of other brokerages have also issued reports on TMO. Zacks Investment Research lowered Thermo Fisher Scientific from a hold rating to a strong sell rating and set a ... |
| 9/21/2021 |
JPMorgan Chase & Co. Increases Thermo Fisher Scientific (NYSE:TMO) Price Target to $700.00 - Mayfield Recorder |
Mayfield Recorder |
Thermo Fisher Scientific (NYSE:TMO) had its price target increased by JPMorgan Chase & Co. from $600.00 to $700.00 in a report released on Monday, The Fly reports. They currently have an overweight rating on the medical research company’s stock.A number of other equities research analysts have also recently issued reports on the stock. Benchmark began coverage on shares of Thermo Fisher Scientific in a research note on Friday ... |
| 9/21/2021 |
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $620.00 at Citigroup |
slatersentinel.com |
Thermo Fisher Scientific (NYSE:TMO) had its price objective lifted by Citigroup from $535.00 to $620.00 in a research report released on Monday morning, The Fly reports. The firm currently has a neutral rating on the medical research company’s stock. TMO has been the topic of several other reports. KeyCorp lifted their price objective on Thermo Fisher Scientific from $520.00 to $555.00 and gave the company an overweight rating ... |
| 9/21/2021 |
Thermo Fisher Scientific (NYSE:TMO) PT Raised to $620.00 |
rivertonroll.com |
Thermo Fisher Scientific (NYSE:TMO) had its price objective boosted by Citigroup from $535.00 to $620.00 in a research note issued to investors on Monday, The Fly reports. Citigroup currently has a neutral rating on the medical research company’s stock. TMO has been the topic of a number of other research reports. Robert W. Baird upped their price target on shares of Thermo Fisher Scientific from $545.00 to $550.00 ... |
| 9/21/2021 |
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $675.00 |
Dakota Financial News |
Thermo Fisher Scientific (NYSE:TMO) had its target price raised by SVB Leerink from $600.00 to $675.00 in a report published on Monday morning, The Fly reports. The brokerage currently has an outperform rating on the medical research company’s stock. A number of other brokerages have also recently commented on TMO. Zacks Investment Research cut shares of Thermo Fisher Scientific from a hold rating to a strong sell rating ... |
| 9/21/2021 |
Thermo Fisher Scientific (NYSE:TMO) Now Covered by Jefferies Financial Group |
dispatchtribunal.com |
Jefferies Financial Group started coverage on shares of Thermo Fisher Scientific (NYSE:TMO) in a research note released on Monday, Price Targets.com reports. The firm issued a hold rating and a $540.00 price target on the medical research company’s stock. A number of other research analysts have also recently weighed in on the stock. SVB Leerink boosted their price objective on shares of Thermo Fisher Scientific from $600.00 to ... |
| 9/21/2021 |
Thermo Fisher Scientific (NYSE:TMO) Now Covered by Analysts at Jefferies Financial Group |
thelincolnianonline.com |
Jefferies Financial Group started coverage on shares of Thermo Fisher Scientific (NYSE:TMO) in a report published on Monday morning, Price Targets.com reports. The brokerage issued a hold rating and a $540.00 target price on the medical research company’s stock. Several other equities research analysts also recently commented on the stock. JPMorgan Chase & Co. boosted their target price on shares of Thermo Fisher Scientific from $600.00 to $700.00 and ... |
| 9/20/2021 |
Grace Capital Decreases Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) |
wkrb13.com |
Grace Capital lessened its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 32.3% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 6,300 shares of the medical research company’s stock after selling 3,000 shares during the quarter. Grace Capital’s holdings in NeoGenomics were worth $285,000 at the end of the most recent quarter.A number of other large investors also recently added to or reduced their ... |
| 9/20/2021 |
Grace Capital Sells 3,000 Shares of NeoGenomics, Inc. (NASDAQ:NEO) |
rivertonroll.com |
Grace Capital trimmed its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 32.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,300 shares of the medical research company’s stock after selling 3,000 shares during the quarter. Grace Capital’s holdings in NeoGenomics were worth $285,000 at the end of the most recent quarter. Other institutional ... |
| 9/20/2021 |
State Board of Administration of Florida Retirement System Sells 12,499 Shares of Bruker Co. (NASDAQ:BRKR) - WKRB News |
wkrb13.com |
State Board of Administration of Florida Retirement System lessened its position in shares of Bruker Co. (NASDAQ:BRKR) by 8.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 144,128 shares of the medical research company’s stock after selling 12,499 shares during the period. State Board of Administration of Florida Retirement System owned 0.10% of Bruker worth $10,951,000 at the ... |
| 9/20/2021 |
State Board of Administration of Florida Retirement System Cuts Stake in Bruker Co. (NASDAQ:BRKR) |
zolmax.com |
State Board of Administration of Florida Retirement System trimmed its position in shares of Bruker Co. (NASDAQ:BRKR) by 8.0% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 144,128 shares of the medical research company’s stock after selling 12,499 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Bruker were worth $10,951,000 as of its most recent SEC filing. Other hedge funds ... |
| 9/20/2021 |
State Board of Administration of Florida Retirement System Sells 12,499 Shares of Bruker Co. (NASDAQ:BRKR) |
American Banking News |
State Board of Administration of Florida Retirement System lessened its position in shares of Bruker Co. (NASDAQ:BRKR) by 8.0% in the second its most recent disclosure with the Securities & Exchange Commission. The fund owned 144,128 shares of the medical research company’s stock after selling 12,499 shares during the period. State Board of Administration of Florida Retirement System owned 0.10% of Bruker worth $10,951,000 at the end of the ... |
| 9/20/2021 |
Toronto Dominion Bank Sells 5,521 Shares of PerkinElmer, Inc. (NYSE:PKI) - WKRB News |
wkrb13.com |
Toronto Dominion Bank trimmed its holdings in shares of PerkinElmer, Inc. (NYSE:PKI) by 10.1% in the second quarter, according to its most recent filing with the SEC. The firm owned 49,127 shares of the medical research company’s stock after selling 5,521 shares during the period. Toronto Dominion Bank’s holdings in PerkinElmer were worth $7,585,000 as of its most recent filing with the SEC.Other large investors have ... |
| 9/20/2021 |
BetterUp Names Omar Dawood President of BetterUp Care‚Ñ¢ |
Yahoo News |
... global leader in mental fitness and whole person transformation for the enterprise, has appointed Omar Dawood MD, MPH, MBA as President of BetterUp Care‚Ñ¢.Dawood brings more than 25 years of senior management, medical research , and clinical experience, most recently serving as the Chief Medical Officer and Head of Sales for Calm. Prior to that, Dr. Dawood served as President and Chief Medical Officer of Ginger and Ginger Medical ... |
| 9/20/2021 |
BetterUp Names Omar Dawood President of BetterUp Care‚Ñ¢ | News | bakersfield.com - The Bakersfield Californian |
Business Wire |
... global leader in mental fitness and whole person transformation for the enterprise, has appointed Omar Dawood MD, MPH, MBA as President of BetterUp Care‚Ñ¢. Dawood brings more than 25 years of senior management, medical research , and clinical experience, most recently serving as the Chief Medical Officer and Head of Sales for Calm. Prior to that, Dr. Dawood served as President and Chief Medical Officer of Ginger and Ginger Medical ... |
| 9/20/2021 |
Thermo Fisher Scientific (NYSE:TMO) Given New $700.00 Price Target at JPMorgan Chase & Co. |
com-unik.info |
Thermo Fisher Scientific (NYSE:TMO) had its price target hoisted by research analysts at JPMorgan Chase & Co. from $600.00 to $700.00 in a research report issued on Monday, The Fly reports. The firm presently has an “overweight” rating on the medical research company’s stock. JPMorgan Chase & Co. ‘s price target would suggest a potential upside of 17.29% from the company’s current price. Several other equities analysts also ... |
| 9/20/2021 |
Thermo Fisher Scientific (NYSE:TMO) Given New $620.00 Price Target at Citigroup |
American Banking News |
Thermo Fisher Scientific (NYSE:TMO) had its target price lifted by Citigroup from $535.00 to $620.00 in a research report issued on Monday, The Fly reports. The brokerage currently has a “neutral” rating on the medical research company’s stock. Citigroup’s price target indicates a potential upside of 3.89% from the stock’s current price.Other equities research analysts also recently issued research reports about the stock. Zacks ... |
| 9/20/2021 |
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Susquehanna Fundamental Investments LLC - American Banking News |
American Banking News |
Susquehanna Fundamental Investments LLC cut its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 70.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,656 shares of the medical research company’s stock after selling 32,974 shares during the quarter. Susquehanna Fundamental Investments LLC’s holdings in Thermo Fisher Scientific were worth $6,889,000 at the end of ... |
| 9/20/2021 |
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Susquehanna Fundamental Investments LLC |
dispatchtribunal.com |
Susquehanna Fundamental Investments LLC cut its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 70.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,656 shares of the medical research company’s stock after selling 32,974 shares during the quarter. Susquehanna Fundamental Investments LLC’s holdings in Thermo Fisher Scientific were worth $6,889,000 at the end of ... |